1. Home
  2. WST vs LII Comparison

WST vs LII Comparison

Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$236.61

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$506.19

Market Cap

17.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
LII
Founded
1923
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
17.7B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
WST
LII
Price
$236.61
$506.19
Analyst Decision
Buy
Hold
Analyst Count
7
13
Target Price
$338.00
$600.17
AVG Volume (30 Days)
825.9K
366.3K
Earning Date
02-12-2026
01-28-2026
Dividend Yield
0.37%
1.02%
EPS Growth
0.17
12.46
EPS
6.75
23.67
Revenue
$3,017,900,000.00
$5,345,300,000.00
Revenue This Year
$6.97
N/A
Revenue Next Year
$6.27
$6.38
P/E Ratio
$35.05
$21.54
Revenue Growth
4.92
3.77
52 Week Low
$187.43
$443.19
52 Week High
$348.90
$689.44

Technical Indicators

Market Signals
Indicator
WST
LII
Relative Strength Index (RSI) 27.79 48.12
Support Level $244.70 $500.75
Resistance Level $258.74 $522.27
Average True Range (ATR) 10.77 15.61
MACD -4.09 -1.70
Stochastic Oscillator 8.06 30.62

Price Performance

Historical Comparison
WST
LII

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About LII Lennox International Inc.

Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.

Share on Social Networks: